Lee Hyun-ju named as the representative of ZP Therapeutics
By Eo, Yun-Ho | translator Hong, Ji Yeon
24.11.14 05:31:21
°¡³ª´Ù¶ó
0
Previously worked as Daiichi Sankyo Korea's Oncology Business Franchise Head
¡ãLee Hyun-ju, new representative of ZP Therapeutics Korea
Lee Hyun-ju (48), ex-Daiichi Sankyo Korea's Oncology Business Franchise Head, was appointed as the new representative of ZP Therapeutics Korea.Industry sources said Zuellig Pharma has recruited Lee Hyun-ju as the new head of ZP Therapeutics Korea, Zuellig Pharma's commercial services corporation.
Lee holds a degree from Sungkyunkwan University's College of Pharmacy, and she has years of experience in the Korean pharmaceutical market with expertise in the anticancer business.
Lee started her career in 1999, undertook roles in Handok's marketing and Sanofi's marketing, and worked as Roche Korea's Oncology Cluster Lead and Novartis Korea's Hematology Cluster Lead. Lee move
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)